Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), J Pediatric Infect Dis Soc
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study.
Tiley KS. et al, (2025), J Infect
Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
Dierig A. et al, (2025), Vaccine X, 24
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.
Dyson ZA. et al, (2025), Genome Med, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Dold C. et al, (2025), Sci Transl Med, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Siegal EZ. et al, (2025), NPJ Vaccines, 10
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.
Viz-Lasheras S. et al, (2025), iScience, 28
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.
El Safadi D. et al, (2025), J Infect Dis, 231, e17 - e27
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.
Khanam F. et al, (2025), BMC Infect Dis, 25
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial.
Conlin K. et al, (2025), Vaccine, 45
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
Viz-Lasheras S. et al, (2025), Nat Commun, 16
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Amodio D. et al, (2025), Vaccine, 43
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Kristensen M. et al, (2024), Cell Rep Med, 5
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Terstappen J. et al, (2024), Lancet Infect Dis, 24, e747 - e761